This report provides estimates of Australia's health system expenditure on care for those with cancer and on the prevention and treatment of cancer. The report presents cancer expenditure by age group, sex and type of cancer, and it compares health system expenditure on cancer in 2008-09 to 2004-05 and 2000-01 in constant prices (see Glossary)...

Executive summary Does antibiotic resistance exist? Yes. It is a worsening phenomenon seen all over the world, including Australia. What are the implications of antibiotic resistance? Infection with antibiotic-resistant bacteria is associated with longer length of stay in hospitals and higher death rates. This amounts to significant financial costs; the European Union, for example, spends...

This report argues that Australia has a long way to go before consumers pay fair prices for pharmaceuticals. Overview Grattan Institute’s March 2013 report, Australia’s bad drug deal, showed that Australians paid more than $1 billion a year too much for prescription drugs. The problem is how the government sets prices. Vested interests are involved...

This report outlines the workforce characteristics of nurses and midwives in 2012.

This paper presents a set of performance indicators for monitoring neonatal hearing screening activity in Australia at a national level, to help measure how well neonatal hearing screening is achieving its aims. Summary Each year in Australia approximately 551 children are born with moderate to profound permanent childhood hearing impairment. Universal neonatal hearing screening aims...